Faes Farma SA
MAD:FAE
Intrinsic Value
The intrinsic value of one FAE stock under the Base Case scenario is 3.001 EUR. Compared to the current market price of 3.475 EUR, Faes Farma SA is Overvalued by 14%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Faes Farma SA
Fundamental Analysis

Revenue & Expenses Breakdown
Faes Farma SA
Balance Sheet Decomposition
Faes Farma SA
Current Assets | 346.9m |
Cash & Short-Term Investments | 69.8m |
Receivables | 138.2m |
Other Current Assets | 138.9m |
Non-Current Assets | 490.6m |
Long-Term Investments | 1.7m |
PP&E | 289.6m |
Intangibles | 184.6m |
Other Non-Current Assets | 14.7m |
Free Cash Flow Analysis
Faes Farma SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Faes Farma SA
Revenue
|
487.4m
EUR
|
Cost of Revenue
|
-163.1m
EUR
|
Gross Profit
|
324.3m
EUR
|
Operating Expenses
|
-214.5m
EUR
|
Operating Income
|
109.8m
EUR
|
Other Expenses
|
-12.2m
EUR
|
Net Income
|
97.6m
EUR
|
FAE Profitability Score
Profitability Due Diligence
Faes Farma SA's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Faes Farma SA's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
FAE Solvency Score
Solvency Due Diligence
Faes Farma SA's solvency score is 92/100. The higher the solvency score, the more solvent the company is.
Score
Faes Farma SA's solvency score is 92/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FAE Price Targets Summary
Faes Farma SA
According to Wall Street analysts, the average 1-year price target for FAE is 3.672 EUR with a low forecast of 3.232 EUR and a high forecast of 4.2 EUR.
Dividends
Current shareholder yield for FAE is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one FAE stock under the Base Case scenario is 3.001 EUR.
Compared to the current market price of 3.475 EUR, Faes Farma SA is Overvalued by 14%.